Wren Laboratories LLC: Clinical Trials

7 trials sponsored by Wren Laboratories LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 enrolling by invitation, 2 completed, 1 active not recruiting, 1 recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Active not recruiting 1, Completed 1

Follow Wren Laboratories LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Probiotics in Wellbeing
Probiotic Supplementation (Lactobacillus plantarum), Daily oral administration of one matched placebo capsule for 12 weeks. The placebo contains potato starch in place of the probiotic bacterial mass and is matched to the active intervention. - Healthy Participants
Not applicableActive not recruitingUniversity of Reading402026-09-012026-09-24
A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth
PROSTEST - Prostate Cancer, Urology
RecruitingWren Laboratories LLC15002026-04-152026-08-21
RNA Assays for Endometriosis Detection and Diagnosis
EndoDx - Endometriosis
Enrolling by invitationWren Laboratories LLC4002024-01-012025-04-02
RegisterPROS - A Registry for Prostate Cancers
PROSTest - Prostate Cancer (Adenocarcinoma), Prostate Biopsy
Enrolling by invitationWren Laboratories LLC10002020-01-152026-08-21
Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy
Blood draw (before surgery), Blood draw (every 3 months), Blood draw (at diagnosis) - Melanoma
CompletedVanderbilt-Ingram Cancer Center372017-10-032023-12-14
Surgical Intervention and the NETest
Surgery - Neuroendocrine Tumor, Gastroenteropancreatic
Not applicableCompletedWren Laboratories LLC302017-05-152026-08-21
RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide
NETest - Neuroendocrine Tumor, Carcinoid
Enrolling by invitationWren Laboratories LLC4002015-02-012025-11-13

Conditions studied

Disease (2)  ·  Neuroendocrine Tumors (2)  ·  Prostatic Neoplasms (2)  ·  Adenocarcinoma (1)  ·  Carcinoid Tumor (1)  ·  Carcinoma, Neuroendocrine (1)  ·  Disease Progression (1)  ·  Endometriosis (1)  ·  Melanoma (1)

Interventions

Blood Specimen Collection (1)  ·  Surgical Procedures, Operative (1)

Countries

United States (4)  ·  Germany (1)  ·  Italy (1)  ·  South Africa (1)  ·  United Kingdom (1)

Top investigators

Abdel Halim, PhD, PharmD (1)  ·  Abdel Halim, PharmD, PhD (1)  ·  Kambiz Rahbar, MD (1)  ·  Rondi Kauffmann, MD (1)

Results publications

PMID 26032155, PMID 26370353, PMID 26456125, PMID 30158287, PMID 32392558, PMID 39945192, PMID 40640763